Jul 12, 2023
|
Lumos Pharma to Participate in the Oppenheimer 2023 Montauk Life Sciences Summit
|
|
Jun 28, 2023
|
Lumos Pharma Announces Departure of Chief Medical Officer
|
|
Jun 21, 2023
|
Lumos to Highlight New LUM-201 Data and Analysis Presented at ENDO 2023 in Virtual KOL Webinar
|
|
May 31, 2023
|
Lumos Pharma to Participate in the Upcoming 2023 BIO International Convention and the Jefferies Healthcare Conference
|
|
May 25, 2023
|
Lumos Pharma Announces Abstracts Accepted for Oral Presentation at 2023 ENDO Meeting with Virtual KOL Event to be Held on June 21st
|
|
May 22, 2023
|
Lumos Pharma to Participate in World Orphan Drug Congress USA
|
|
May 8, 2023
|
Encouraging Data from Lumos Pharma OraGrowtH Trials Presented at Annual Pediatric Endocrine Society Meeting (PES)
|
|
May 3, 2023
|
Lumos Pharma Reports First Quarter 2023 Financial Results, Provides Clinical Updates
|
|
Apr 27, 2023
|
Data from Lumos Pharma OraGrowtH Trials to be Presented at Annual Pediatric Endocrine Society Meeting (PES)
|
|
Apr 19, 2023
|
Lumos Pharma to Report First Quarter 2023 Financial Results and Host Conference Call on May 3, 2023
|
|